[Alzheimer disease. Pseudo-irreversible AChE inhibition with rivastigmine].
出版信息
Med Monatsschr Pharm. 1998 Aug;21(8):248-9.
PMID:9758554
Abstract
摘要
相似文献
1
[Alzheimer disease. Pseudo-irreversible AChE inhibition with rivastigmine].[阿尔茨海默病。卡巴拉汀的假性不可逆性乙酰胆碱酯酶抑制作用]
Med Monatsschr Pharm. 1998 Aug;21(8):248-9.
2
Rivastigmine (Exelon) for Alzheimer's disease.卡巴拉汀（艾斯能）用于治疗阿尔茨海默病。
Med Lett Drugs Ther. 2000 Oct 2;42(1089):93-4.
3
[Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
Ned Tijdschr Geneeskd. 2002 Mar 9;146(10):494.
4
Rivastigmine for Alzheimer's disease.卡巴拉汀用于治疗阿尔茨海默病。
Drug Ther Bull. 2000 Feb;38(2):15-6.
5
The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.卡巴拉汀的临床益处可能反映了其双重抑制作用模式：一种假说。
Int J Clin Pract. 2002 Apr;56(3):206-14.
6
7
[Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].[阿尔茨海默病性痴呆。胆碱酯酶抑制剂与银杏的疗效比较]
MMW Fortschr Med. 2001 Dec 13;143(51-52):40-1.
8
Brief review: rivastigmine, a second cholinesterase inhibitor.
Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293.
9
Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.阿尔茨海默病治疗进展：双重胆碱酯酶抑制的益处
Eur Neurol. 2002;47(1):64-70. doi: 10.1159/000047952.
10
Do cholinesterase inhibitors slow progression of Alzheimer's disease?胆碱酯酶抑制剂能延缓阿尔茨海默病的进展吗？
Int J Clin Pract Suppl. 2002 Jun(127):37-44.
Zotero 插件